Back
ProShares S&P 500® ex-Energy Vs. Neurogene Industry Stock Comparison
Buy
64
SPXE
ProShares S&P 500® ex-Energy
Last Price:
64.43
Seasonality Move:
5.66%
Sell
1
NGNE
Neurogene
Last Price:
34.67
Seasonality Move:
50.43%
Buy
64
ProShares S&P 500® ex-Energy (SPXE)
is a Buy
Is ProShares S&P 500® ex-Energy a Buy, Sell or Hold?
- The current ProShares S&P 500® ex-Energy [SPXE] share price is $63.04. The Score for SPXE is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
- SPXE is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
1
Neurogene (NGNE)
is a Sell
Is Neurogene a Buy, Sell or Hold?
- The current Neurogene [NGNE] share price is $34.52. The Score for NGNE is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
- NGNE is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
SPXE Stock Price Chart
What is ProShares S&P 500® ex-Energy's stock price today?
-
The ProShares S&P 500® ex-Energy share price today is $63.04
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SPXE is experiencing selling pressure, which indicates risk of future bearish movement.
SPXE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.56 | Buy |
| Relative Strength Index (14 RSI): | 51.98 | Buy |
| Chaikin Money Flow: | -641 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (62 - 63.82) | Buy |
| Bollinger Bands (100): | (58.54 - 62.46) | Buy |
NGNE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.55 | Sell |
| Relative Strength Index (14 RSI): | 35.74 | Sell |
| Chaikin Money Flow: | -452975 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (41.4 - 61.5) | Sell |
| Bollinger Bands (100): | (34.32 - 50.52) | Sell |
SPXE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 64.02 | Sell |
| 20-day SMA: | 62.95 | Buy |
| 50-day SMA: | 62 | Buy |
| 200-day SMA: | 57.98 | Buy |
| 8-day EMA: | 63.62 | Sell |
| 20-day EMA: | 63.1 | Sell |
| 50-day EMA: | 62.06 | Buy |
| 200-day EMA: | 57.96 | Buy |
NGNE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 53.3 | Sell |
| 20-day SMA: | 51.47 | Sell |
| 50-day SMA: | 46.76 | Sell |
| 200-day SMA: | 38.99 | Sell |
| 8-day EMA: | 47.13 | Sell |
| 20-day EMA: | 50.2 | Sell |
| 50-day EMA: | 47.47 | Sell |
| 200-day EMA: | 38.44 | Sell |
ProShares S&P 500® ex-Energy Earnings Growth & SPXE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Neurogene Earnings Growth & NGNE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.90 per share.
ProShares S&P 500® ex-Energy Technical Analysis
| Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Neurogene Technical Analysis
| Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||